Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

Description

The investigators propose to genotype males and females at age 40 years and older, who are asymptomatic and without known heart disease (N=2000). DNA from a blood sample will be genotyped for millions of genetic risk variants for CAD by Baylor College of Medicine Human Genome Sequencing Center Clinical Laboratory (HGSC-CL) in a CLIA-approved laboratory. The overall objective after 2 years is to determine if genetic screening for risk of CAD in asymptomatic men and women has the discriminatory power to detect those at highest risk who would potentially benefit most from appropriate primary prevention. It will also determine whether the GRS is appropriate for different ethnic and race groups such as Hispanics, African Americans and Whites, and to what extent those individuals knowing that they are at higher risk, are more likely to seek further advice on management of the risks (either through changes in lifestyle or therapy).

Conditions

Coronary Artery Disease, Genetic Predisposition to Disease

Study Overview

Study Details

Study overview

The investigators propose to genotype males and females at age 40 years and older, who are asymptomatic and without known heart disease (N=2000). DNA from a blood sample will be genotyped for millions of genetic risk variants for CAD by Baylor College of Medicine Human Genome Sequencing Center Clinical Laboratory (HGSC-CL) in a CLIA-approved laboratory. The overall objective after 2 years is to determine if genetic screening for risk of CAD in asymptomatic men and women has the discriminatory power to detect those at highest risk who would potentially benefit most from appropriate primary prevention. It will also determine whether the GRS is appropriate for different ethnic and race groups such as Hispanics, African Americans and Whites, and to what extent those individuals knowing that they are at higher risk, are more likely to seek further advice on management of the risks (either through changes in lifestyle or therapy).

Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

Condition
Coronary Artery Disease
Intervention / Treatment

-

Contacts and Locations

Chandler

Chandler Regional Medical Center, Chandler, Arizona, United States, 85224

Gilbert

Mercy Gilbert Medical Center, Gilbert, Arizona, United States, 85297

Phoenix

St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States, 85013

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Males 40 to 60 years of age
  • * Females 40 to 60 years of age
  • * No known cardiovascular disease
  • * Willing and able to sign consent
  • * Prisoners
  • * Prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
  • * Known ischemia on non-invasive testing
  • * Ischemic cerebrovascular event
  • * Peripheral arterial disease

Ages Eligible for Study

40 Years to 60 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

St. Joseph's Hospital and Medical Center, Phoenix,

Robert Roberts, MD, PRINCIPAL_INVESTIGATOR, Dignity Health

Study Record Dates

2024-06-15